Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids

Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids

Phosphatidylinositol 3-kinases (PI3K) form a family of lipid kinases that catalyze the phosphorylation of 3-hydroxyl group of the inositol ring of phosphatidylinositol and its derivatives. It is implicated in inflammatory disorders and cancer thus making it an attractive drug target. Crystal structu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sagar Rathee, Madhan Vishal Rajan, Simran Sharma, Gururao Hariprasad
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Biochemistry and Biophysics Reports
Subjects:	Phosphatidylinositol 3-kinase γ Stilbenoids Drug target Structural based drug design Interactions Potency
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405580824002255
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibition of protein kinase D and its substrate phosphatidylinositol-4 kinase III beta blocks common human coronavirus replication
by: Huijuan Han, et al.
Published: (2024-12-01)

New Derivatives of Chalcones, Chromenes, and Stilbenoids, Complexed with Methyl-β-Cyclodextrin with Antioxidant Properties and Antibacterial Synergism with Antibiotics
by: Igor D. Zlotnikov, et al.
Published: (2024-12-01)

Current research on determination of medically valued stilbenes and stilbenoids from spruce and pine with chromatographic and spectrometric methods—A review
by: Heli Sirén
Published: (2024-11-01)

Chemical Synthesis of 6-Azido-6-Deoxy Derivatives of Phosphatidylinositol Containing Different Fatty Acid Chains
by: Mosidur Rahaman Molla, et al.
Published: (2024-10-01)

Exploring the antifungal potential of Cannabis sativa-derived stilbenoids and cannabinoids against novel targets through in silico protein interaction profiling
by: Kevser Kübra Kırboğa, et al.
Published: (2025-01-01)

Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer
by: Agnieszka Chytła, et al.
Published: (2025-02-01)

Cyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases
by: Lorena Martínez-Alcantar, et al.
Published: (2024-12-01)

Phosphatidylinositol promoted the proliferation and invasion of pituitary adenoma cells by regulating POU1F1 expression
by: Tongjiang Xu, et al.
Published: (2025-01-01)

Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
by: Guanting Li, et al.
Published: (2025-01-01)

Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
by: Song Liya, et al.
Published: (2024-12-01)

Icaritin alleviates motor impairment and osteoporosis in Parkinson’s disease mice via the ER-PI3K/Akt pathway
by: Xianmei Lin, et al.
Published: (2025-01-01)

Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
by: Mónica Fernandes-Pineda, et al.
Published: (2024-12-01)

Expanding the therapeutic horizon in acute myeloid leukemia: The role of phosphoinositide-3-kinase-γ inhibition
by: Soumyajit Das, et al.
Published: (2024-12-01)

Development of 6-amido-4-aminoisoindolyn-1,3-diones as p70S6K1 inhibitors and potential breast cancer therapeutics
by: Adrian Thornton, et al.
Published: (2024-12-01)

Molecular characterization and analysis of the drug resistance-associated protein phosphoglycerate kinase of Eimeria tenella
by: Yu Yu, et al.

In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities
by: Fatima-Zahrae Laaboudi, et al.
Published: (2024-12-01)

Naringenin, a Food Bioactive Compound, Reduces Oncostatin M Through Blockade of PI3K/Akt/NF-κB Signal Pathway in Neutrophil-like Differentiated HL-60 Cells
by: Na-Ra Han, et al.
Published: (2025-01-01)

Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels
by: Delgado-Ramírez Mayra, et al.
Published: (2021-06-01)

The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies
by: Hannah M. Hicks, et al.
Published: (2024-12-01)

PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives
by: Tianlong Liu, et al.
Published: (2025-10-01)

Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved]
by: Peter Mwitari, et al.
Published: (2023-10-01)

Approaches to Enhance the Potency of Vaccines in Chickens
by: Oenone Bodman-Harris, et al.
Published: (2024-11-01)

Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials
by: José Pinto-Fraga, et al.
Published: (2025-02-01)

Statistical and Clustering Analysis of Safety Profiles of FDA-Approved Protein Kinase Inhibitors
by: Ioana Lavinia Radulian, et al.
Published: (2024-12-01)

Functional Characterization of the SHIP1-Domains Regarding Their Contribution to Inositol 5-Phosphatase Activity
by: Spike Murphy Müller, et al.
Published: (2025-01-01)

Targeting AMP‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
by: Alicia Bort, et al.
Published: (2019-05-01)

Bruton’s tyrosine kinase inhibitor associated localized extremity edema and erythema
by: Shannon Meledathu, BS, et al.
Published: (2024-12-01)

A systematic analysis of binary blend cement concrete infused with lime sludge and fly ash
by: V.V. Praveen Kumar, et al.
Published: (2024-12-01)

A multi-model approach identifies ALW-II-41-27 as a promising therapy for osteoarthritis-associated inflammation and endochondral ossification
by: Mauricio N. Ferrao Blanco, et al.
Published: (2024-12-01)

Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11
by: Ling Li, et al.
Published: (2025-01-01)

Measurement uncertainty revealed: The impacts of Certified Reference Material (CRM) on cannabinoid concentrations in the cannabis testing industry
by: Stephen Goldman
Published: (2024-12-01)

Natural Killer Cell-Secreted IFN-γ and TNF-α Mediated Differentiation in Lung Stem-like Tumors, Leading to the Susceptibility of the Tumors to Chemotherapeutic Drugs
by: Kawaljit Kaur, et al.
Published: (2025-01-01)

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
by: Fatih Ciftci, et al.
Published: (2025-01-01)

Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
by: Lu Hu, et al.
Published: (2025-01-01)

Recent approaches in the drug research and development of novel antimalarial drugs with new targets
by: Chinnappanna Naveen Kumar Reddy, et al.
Published: (2023-03-01)

Effect of γ-ethyl-γ-phenyl-butyrolactone (EFBL), anticonvulsant and hypnotic drug, on mouse brain catecholamine levels
by: Rasgado Lourdes A. Vega, et al.
Published: (2017-06-01)

Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple Mutants
by: Steven J. Smith, et al.
Published: (2025-01-01)

Machine Learning-Assisted Drug Repurposing Framework for Discovery of Aurora Kinase B Inhibitors
by: George Nicolae Daniel Ion, et al.
Published: (2024-12-01)

Gene-Silencing Therapeutic Approaches Targeting PI3K/Akt/mTOR Signaling in Degenerative Intervertebral Disk Cells: An In Vitro Comparative Study Between RNA Interference and CRISPR–Cas9
by: Masao Ryu, et al.
Published: (2024-12-01)

Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges
by: Sofija Kozarac, et al.
Published: (2025-01-01)